Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

News

News
08/11/2022
Construction of a nomogram designed to predict overall survival in patients with mucinous ovarian cancer (MOC) may have valuable significant guidance for the clinical diagnosis and management of patients with MOC for clinical evaluation.
Construction of a nomogram designed to predict overall survival in patients with mucinous ovarian cancer (MOC) may have valuable significant guidance for the clinical diagnosis and management of patients with MOC for clinical evaluation.
Construction of a nomogram...
08/11/2022
Journal of Clinical Pathways
News
08/11/2022
A recent study assessed the combined impact of Medicare’s pay for performance (P4P) programs on clinical areas and populations targeted by the programs, as well as those outside their focus, and found that minimal, if any, effect of...
A recent study assessed the combined impact of Medicare’s pay for performance (P4P) programs on clinical areas and populations targeted by the programs, as well as those outside their focus, and found that minimal, if any, effect of...
A recent study assessed the...
08/11/2022
Journal of Clinical Pathways
News
07/27/2022
A survey evaluated first-line therapy preferences for treatment-naïve patients with MCL in routine practice and perceptions surrounding benefits and risks of the lenalidomide plus rituximab plus venetoclax triplet regimen.
A survey evaluated first-line therapy preferences for treatment-naïve patients with MCL in routine practice and perceptions surrounding benefits and risks of the lenalidomide plus rituximab plus venetoclax triplet regimen.
A survey evaluated first-line...
07/27/2022
Journal of Clinical Pathways
News
07/27/2022
Researchers detailed their systematic review protocol which will aim to evaluate the effects of bortezomib on the overall survival, progression-free survival, overall response rate, time to next treatment, health-related quality of life,...
Researchers detailed their systematic review protocol which will aim to evaluate the effects of bortezomib on the overall survival, progression-free survival, overall response rate, time to next treatment, health-related quality of life,...
Researchers detailed their...
07/27/2022
Journal of Clinical Pathways
News
07/14/2022
Findings from a recent real-world analysis on patients with mantle cell lymphoma revealed high attrition rates, as well as a need for more effective treatment options for those in earlier lines of therapy.
Findings from a recent real-world analysis on patients with mantle cell lymphoma revealed high attrition rates, as well as a need for more effective treatment options for those in earlier lines of therapy.
Findings from a recent...
07/14/2022
Journal of Clinical Pathways
News
07/12/2022
Researchers detail current first-line treatment options for the management of metastatic renal cell carcinoma and propose a framework for optimal treatment selection.
Researchers detail current first-line treatment options for the management of metastatic renal cell carcinoma and propose a framework for optimal treatment selection.
Researchers detail current...
07/12/2022
Journal of Clinical Pathways
News
07/08/2022
A panel of expert members of the American Society of Clinical Oncology used informal consensus to develop updated recommendations on the appropriate use of breast cancer biomarker assay results to guide decisions about using adjuvant...
A panel of expert members of the American Society of Clinical Oncology used informal consensus to develop updated recommendations on the appropriate use of breast cancer biomarker assay results to guide decisions about using adjuvant...
A panel of expert members of the...
07/08/2022
Journal of Clinical Pathways
News
07/08/2022
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies to manage classical Hodgkin lymphoma during the DTIC shortage and propose a treatment algorithm based on fitness and safety.
Researchers discuss strategies...
07/08/2022
Journal of Clinical Pathways
News
07/07/2022
A recent article discusses oncology-specific considerations when assessing elements of value, offering some background on the nature and development of quality-adjusted life-years as a part of cost-effectiveness analyses and some of their key...
A recent article discusses oncology-specific considerations when assessing elements of value, offering some background on the nature and development of quality-adjusted life-years as a part of cost-effectiveness analyses and some of their key...
A recent article discusses...
07/07/2022
Journal of Clinical Pathways
News
06/24/2022
Findings from a recent study identified a need for systematic implementation of oncology financial navigation to address patient and caregiver financial hardship.
Findings from a recent study identified a need for systematic implementation of oncology financial navigation to address patient and caregiver financial hardship.
Findings from a recent study...
06/24/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement